Selection for growth & income: Sanofi-Aventis (SNY:42.63)
Article Abstract:
The Sanofi-Aventis stock is expected to give its investors good dividends in 2010-2012, provided the company markets more vaccines. Only 8% of Sanofi-Aventis' sales in 2006 came from vaccines, but more income can be expected from this sector. Some of Sanofi-Aventis' products, such as Accomplia, and the formation of the company are also discussed.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Sanofi-Aventis
Article Abstract:
The price appreciation potential of the shares of Sanofi-Aventis for the years 2010-2012 is discussed. The French company offers pharmaceuticals for a variety of therapeutic areas, including cardiovascular, thrombosis and metabolic disorders, and 20 vaccines.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Enzon Pharm. Inc
Article Abstract:
The price appreciation potential of the shares of Enzon Pharmaceuticals Inc. for the years 2010-2012 is discussed. The Bridgewater, New Jersey-based company develops therapeutics for life-threatening diseases using its proprietary technologies.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Selection for growth: Korn/Ferry Int'l (KFY - 20.66). Korn/Ferry Int'l. Stock highlight: Amn Healthcare (AHS - 27.29)
- Abstracts: Selection for growth and income: Hibbett Sports, Inc. (HIBB-28.04). Dick's Sporting
- Abstracts: Selection for growth: Cognos, Inc. Model portfolios: recent developments. Stock highlight: Oracle Corp
- Abstracts: Sonosite Inc. SonoSite, Inc. AngioDynamics, Inc
- Abstracts: National City Corp. Rockwell Collins. Compass Bancshare